According to an analysis published by AllAboutFeed, a combination of price increase announcements, large container shipments, supply delays, low stock levels, and announced factory maintenance has led to some purchasing actions.

Increasing Pressure

There is still growing pressure on vitamin E and vitamin A. Particularly for vitamin A, there is increasing price pressure from the U.S. supplier. Both products have seen slight price increases in recent weeks.

Vitamin D3 500

Vitamin D3 500 shows a firmer tone FOB China, as does vitamin B1 mono. The rising container transport rates are beginning to weigh on the relatively low-priced vitamins.

Vitamin E 50%

The market sentiment remains firmer, showing some buying activity in several regions, although less than in previous weeks. Delays in deliveries, price increase announcements, announced facility maintenance, low stock levels, and decent consumption have led to a firmer market. High container transport costs are also adding to the final price of vitamin E. Prices have increased in most regions, but there is still caution due to doubts about how long this firmer period will last. This has triggered buying in Q3. Q2 is contracted, and much of Q3 is also.

Vitamin A 1000

In the U.S. especially, there are attempts by suppliers to increase the price, citing low stocks and delayed material. Similar potential market disruptions such as price increases, production cuts, maintenance periods, and supply delays are communicated in other regions as well. However, so far, the price has only increased slightly, and buyers have not reacted significantly to these communications. Prices are stable to slightly firmer in most regions. The market is quiet, with most of Q2 contracted and part of Q3 as well.

Vitamin D3 500

FOB China prices are firmer, and some suppliers have stopped offering. There is a strong desire among producers and suppliers to raise prices and move away from relatively low price levels. Price increases are also seen as container transport cost increases become significant now. Prices in the U.S. and Europe have remained relatively stable but could become firmer soon. The market feels quiet despite delays from ex-China, higher container transport costs, and higher FOB prices in China. Q2 is contracted, and part of Q3 is also.

Vitamin B2 80%

There have again been some attempts by suppliers to increase prices, but so far, there has been no market reaction. Overall, the vitamin B2 market remains quiet and stable. Prices in Asia are still relatively low, while prices in Europe and the U.S. are higher. Most of Q2 is contracted, with parts of Q3 also covered.

D-Calpan

A slight price increase is seen as container transport cost increases become more significant. Suppliers are trying to raise prices for new demand, and container price increases could lead to firmer prices, although this impact is relatively limited on the total price per kg. Despite this, prices remain stable in most regions at a low level, as supply is generally ample and suppliers are eager to maintain market share and move stocks. A decent coverage for Q2 has already been taken. Q3 is still largely uncovered.

Vitamin B3

Most suppliers have stopped cutting prices, and a firmer tone is now seen. Demand is still slow, so a significant price increase is unlikely in the short term. Overall, the market feels quiet, and prices are mostly stable at a relatively low level. Any observed increase is driven by higher container transport rates. Availability seems to be OK in most regions. Some coverage for T2 and even early T3 has already been taken when prices stabilized at a low level.

Biotin

There have been some attempts by producers to increase prices, but it hasn't worked. Supply is ample, and long-term contracts have been concluded or are pending. The market is quiet, and even slightly lower prices have been observed again for both pure biotin and lower-content 2% material. Prices remain historically low. Most of Q2 is contracted, and part of Q3 is too. In some cases, buyers have signed long-term contracts through the end of 2024.

Vitamin C 35% mono

Even though some producers have indicated they would reduce production, market sentiment has become slightly weak in recent weeks. No major changes are observed, but in some regions, vitamin C prices have slightly decreased, and demand is slow.